TERBINAFINE-WT terbinafine (as hydrochloride) 250 mg tablet blister pack

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

terbinafine hydrochloride, Quantity: 281.28 mg

Dostupné s:

Medis Pharma Pty Ltd

INN (Mezinárodní Name):

terbinafine hydrochloride

Léková forma:

Tablet, uncoated

Složení:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type A; magnesium stearate; hypromellose

Podání:

Oral

Jednotky v balení:

42

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

? Treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as Trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. ? Onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

Přehled produktů:

Visual Identification: White to off-white, uncoated biconvex, bevelled edge tablet, engraved 'TER' and '250' with a break line on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Stav Autorizace:

Licence status A

Datum autorizace:

2014-03-20